Marzia Varettoni (M Varettoni)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Venues

American journal of hematology

Hematological oncology

Cancers

British journal of haematology

Fondazione IRCCS Policlinico San Matteo

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fondazione IRCCS Policlinico San Matteo Nov 02 2008

Italy

MD :: Division of Hematology

Publications

Criscuolo Marianna, Maria Elena Tosti, Alessandro Broccoli, Marzia Varettoni, Alessio Maria Edoardo Maraglino, Antonella Anastasia, Maria Cantonetti, Livio Trentin, Sofia Kovalchuk, Lorella Orsucci, Marina Deodato, Angelica Spolzino, Stefano Volpetti, Ombretta Annibali, Sergio Storti, Caterina Stelitano, Francesco Marchesi, Sonia Morè, Luana Fianchi, Brunangelo Falini, Alessandro Pulsoni, Enrico Tiacci, Pier Luigi Luigi Zinzani, Livio Pagano
Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review. Cancers 16 (8) (2024)
Francesca Romana Mauro, Potito Rosario Scalzulli, Lydia Scarfò, Carla Minoia, Roberta Murru, Paolo Sportoletti, Ferdinando Frigeri, Francesco Albano, Nicola Di Renzo, Alessandro Sanna, Luca Laurenti, Massimo Massaia, Ramona Cassin, Marta Coscia, Caterina Patti, Elsa Pennese, Agostino Tafuri, Annalisa Chiarenza, Piero Galieni, Omar Perbellini, Carmine Selleri, Catello Califano, Felicetto Ferrara, Antonio Cuneo, Marco Murineddu, Gaetano Palumbo, Ilaria Scortechini, Alessandra Tedeschi, Livio Trentin, Marzia Varettoni, Fabrizio Pane, Anna Marina Liberati, Francesco Merli, Lucia Morello, Gerardo Musuraca, Monica Tani, Adalberto Ibatici, Giulia Regazzoni, Michele Di Candia, Maria Palma, Danilo Arienti, Stefano Molica
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study. Cancers 16 (6) (2024)
Francesca Romana Mauro, Potito Rosario Scalzulli, Lydia Scarfò, Carla Minoia, Roberta Murru, Paolo Sportoletti, Ferdinando Frigeri, Francesco Albano, Nicola Di Renzo, Alessandro Sanna, Luca Laurenti, Massimo Massaia, Ramona Cassin, Marta Coscia, Caterina Patti, Elsa Pennese, Agostino Tafuri, Annalisa Chiarenza, Piero Galieni, Omar Perbellini, Carmine Selleri, Catello Califano, Felicetto Ferrara, Antonio Cuneo, Marco Murineddu, Gaetano Palumbo, Ilaria Scortechini, Alessandra Tedeschi, Livio Trentin, Marzia Varettoni, Fabrizio Pane, Anna Marina Liberati, Francesco Merli, Lucia Morello, Gerardo Musuraca, Monica Tani, Adalberto Ibatici, Giulia Regazzoni, Michele Di Candia, Maria Palma, Danilo Arienti, Stefano Molica
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study. Cancers 16 (6) (2024)
Criscuolo Marianna, Maria Elena Tosti, Alessandro Broccoli, Marzia Varettoni, Alessio Maria Edoardo Maraglino, Antonella Anastasia, Maria Cantonetti, Livio Trentin, Sofia Kovalchuk, Lorella Orsucci, Marina Deodato, Angelica Spolzino, Stefano Volpetti, Ombretta Annibali, Sergio Storti, Caterina Stelitano, Francesco Marchesi, Sonia Morè, Luana Fianchi, Brunangelo Falini, Alessandro Pulsoni, Enrico Tiacci, Pier Luigi Luigi Zinzani, Livio Pagano
Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review. Cancers 16 (8) (2024)
Francesca Romana Mauro, Alessandra Tedeschi, Marzia Varettoni, Francesca Romana Mauro, Giovanni Barosi, Pier Luigi Luigi Zinzani
Identifying and addressing unmet clinical needs on the use of zanubrutinib in chronic lymphocytic leukemia: A consensus-based position paper from an ad hoc expert panel. Hematological oncology 42 (2) (2024)
Pier Luigi Luigi Zinzani, Francesca Romana Mauro, Alessandra Tedeschi, Marzia Varettoni, Francesco Zaja, Giovanni Barosi
Unmet clinical needs in the use of zanubrutinib in malignant lymphomas (Waldenström macroglobulinemia, marginal zone lymphoma and mantle cell lymphoma): A consensus-based position paper from an ad hoc expert panel. Hematological oncology (2023)
Pier Luigi Luigi Zinzani, Maurizio Martelli, Simone Ferrero, Massimo Gentile, Luca Laurenti, Francesca Romana Mauro, Paolo Sportoletti, Alessandra Tedeschi, Marzia Varettoni, Chiara Rusconi
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement. Hematological oncology 40 (4) (2022)
Simone Ferrero, Massimo Gentile, Luca Laurenti, Francesca Romana Mauro, Maurizio Martelli, Paolo Sportoletti, Chiara Rusconi, Pier Luigi Luigi Zinzani, Alessandra Tedeschi, Marzia Varettoni
Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statement. Hematological oncology 40 (3) (2022)
Marzia Varettoni, Silvia Zibellini, Michele Merli, Daniela Drandi, Cristina Jiménez, Daniela Furlan, Virginia Valeria Ferretti, Nicole Fabbri, Irene Dogliotti, Chiara Varraso, Martina Ferrante, Emilia Cappello, Veronica Peri, Chiara Cavalloni, Michela Borriero, Giulia Vittoria Facchetti, Simone Ferrero, Luca Arcaini, Ramon Garcia-Sanz
Molecular remission is an independent predictor of progression-free survival in patients with Waldenström macroglobulinemia treated with chemo-immunotherapy: Results from the FIL_BIOWM study. Hematological oncology (2022)
Shai Levi, Yotam Bronstein, Neta Goldschmidt, Fortunato Morabito, Tomer Ziv-Baran, Giovanni Del Poeta, Osnat Bairey, Maria Ilaria Del Principe, Riva Fineman, Francesca Romana Mauro, Odit Gutwein, Gianluigi Reda, Rosa Ruchlemer, Paolo Sportoletti, Luca Laurenti, Lev Shvidel, Marta Coscia, Tamar Tadmor, Marzia Varettoni, Ariel Aviv, Roberta Murru, Andrei Braester, Annalisa Chiarenza, Andrea Visentin, Daniela Pietrasanta, Giacomo Loseto, Antonella Zucchetto, Riccardo Bomben, Jacopo Olivieri, Antonio Neri, Davide Rossi, Gianluca Gaidano, Livio Trentin, Robin Foà, Antonio Cuneo, Chava Perry, Valter Gattei, Massimo Gentile, Yair Herishanu
Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study. American journal of hematology (2022)
Fortunato Morabito, Giovanni Tripepi, Giovanni Del Poeta, Francesca Romana Mauro, Gianluigi Reda, Paolo Sportoletti, Luca Laurenti, Marta Coscia, Yair Herishanu, Marzia Varettoni, Roberta Murru, Annalisa Chiarenza, Andrea Visentin, Adalgisa Condoluci, Riccardo Moia, Daniela Pietrasanta, Giacomo Loseto, Ugo Consoli, Ilaria Scortechini, Francesca Romana Mauro, Antonella Zucchetto, Ernesto Vigna, Enrica Antonia Martino, Francesco Mendicino, Cirino Botta, Daniele Caracciolo, Ramona Cassin, Graziella D'Arrigo, Sara Galimberti, Angela Rago, Ilaria Angeletti, Annalisa Biagi, Ilaria Del Giudice, Riccardo Bomben, Antonino Neri, Gilberto Fronza, Giovanna Cutrona, Davide Rossi, Francesco Di Raimondo, Antonio Cuneo, Gianluca Gaidano, Aaron Polliack, Livio Trentin, Robin Foà, Manlio Ferrarini, Valter Gattei, Massimo Gentile
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. American journal of hematology 96 (5) (2021)
Fortunato Morabito, Giovanni Del Poeta, Francesca Romana Mauro, Gianluigi Reda, Paolo Sportoletti, Luca Laurenti, Marta Coscia, Yair Herishanu, Sabrina Bossio, Marzia Varettoni, Roberta Murru, Annalisa Chiarenza, Andrea Visentin, Adalgisa Condoluci, Riccardo Moia, Daniela Pietrasanta, Giacomo Loseto, Ugo Consoli, Ilaria Scortechini, Anna Grazia Recchia, Francesca Romana Mauro, Antonella Zucchetto, Hamdi Al-Janazreh, Enrica Antonia Martino, Ernesto Vigna, Giovanni Tripepi, Graziella D'Arrigo, Sara Galimberti, Angela Rago, Ilaria Angeletti, Annalisa Biagi, Ilaria Del Giudice, Riccardo Bomben, Antonino Neri, Gilberto Fronza, Giovanna Cutrona, Ozren Jaksic, Jacopo Olivieri, Davide Rossi, Francesco Di Raimondo, Antonio Cuneo, Gianluca Gaidano, Aaron Polliack, Livio Trentin, Robin Foà, Manlio Ferrarini, Valter Gattei, Massimo Gentile
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases. American journal of hematology 96 (8) (2021)
Marzia Varettoni, Ester Orlandi, Silvia Zibellini, Marianna Rossi, Massimo Gentile, Elena Flospergher, Virginia V Ferretti, Ettore Rizzo, Matteo G Della Porta, Sara Rattotti, Chiara Cavalloni, Fabio Bergamini, Caterina Cristinelli, Nicole Fabbri, Anna Gallì, Luca Arcaini
Prognostic impact of somatic mutations on time to first treatment: Results of targeted next-generation sequencing in 211 patients with early stage chronic lymphocytic leukemia. American journal of hematology 96 (11) (2021)
Fortunato Morabito, Giovanni Tripepi, Giovanni Del Poeta, Francesca Romana Mauro, Gianluigi Reda, Paolo Sportoletti, Luca Laurenti, Marta Coscia, Yair Herishanu, Sabrina Bossio, Marzia Varettoni, Roberta Murru, Annalisa Chiarenza, Andrea Visentin, Adalgisa Condoluci, Riccardo Moia, Daniela Pietrasanta, Giacomo Loseto, Ugo Consoli, Ilaria Scortechini, Francesca Romana Mauro, Antonella Zucchetto, Hamdi Al-Janazreh, Ernesto Vigna, Enrica Antonia Martino, Ramona Cassin, Graziella D Arrigo, Sara Galimberti, Angela Rago, Ilaria Angeletti, Annalisa Biagi, Ilaria Del Giudice, Riccardo Bomben, Antonino Neri, Gilberto Fronza, Paola Menichini, Paola Menichini, Jacopo Olivieri, Giovanna Cutrona, Davide Rossi, Antonio Cuneo, Francesco Di Raimondo, Gianluca Gaidano, Aaron Polliack, Livio Trentin, Robin Foà, Manlio Ferrarini, Valter Gattei, Massimo Gentile
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials. American journal of hematology 96 (8) (2021)
Irene Defrancesco, Marcella Visentini, Silvia Zibellini, Ylenia Aura Minafò, Sara Rattotti, Virginia Valeria Ferretti, Ettore Rizzo, Marzia Varettoni, Marco Frigeni, Alessandro Pulsoni, Milvia Casato, Stefania Colantuono, Marianna Rossi, Chiara Candido, Caterina Zerbi, Fabio Bergamini, Caterina Cristinelli, Nicole Fabbri, Michele Merli, Valentina Zuccaro, Raffaele Bruno, Marco Paulli, Luca Arcaini
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders. American journal of hematology 96 (6) (2021)
Marzia Varettoni, Angela Ferrari, Anna M Frustaci, Virginia V Ferretti, Rita Rizzi, Marina Motta, Francesco Piazza, Michele Merli, Giulia Benevolo, Carlo Visco, Luca Laurenti, Simone Ferrero, Massimo Gentile, Vittorio Del Fabro, Antonio Abbadessa, Catherine Klersy, Pellegrino Musto, Nicole Fabbri, Marina Deodato, Irene Dogliotti, Corinna Greco, Andrea Corbingi, Stefano Luminari, Luca Arcaini
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies. American journal of hematology 95 (12) (2020)
Andrea Corbingi, Idanna Innocenti, Annamaria Tomasso, Raffaella Pasquale, Andrea Visentin, Marzia Varettoni, Elena Flospergher, Francesco Autore, Francesca Morelli, Livio Trentin, Gianluigi Reda, Dimitar G Efremov, Luca Laurenti
Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia. British journal of haematology 190 (6) (2020)
Marzia Varettoni, Emanuela Boveri, Silvia Zibellini, Alessandra Tedeschi, Chiara Candido, Virginia Valeria Ferretti, Ettore Rizzo, Elisa Doni, Michele Merli, Lucia Farina, Maria Goldaniga, Anna Gallì, Sara Rattotti, Anna Maria Frustaci, Marina Deodato, Laura Bandiera, Giuseppe Isimbaldi, Silvia Uccella, Antonello Domenico Cabras, Umberto Gianelli, Luca Baldini, Marco Paulli, Luca Arcaini
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network. American journal of hematology 94 (11) (2019)
Marzia Varettoni, Silvia Zibellini, Emanuela Boveri, Catherine Klersy, Chiara Candido, Sara Rattotti, Virginia V Ferretti, Irene Defrancesco, Silvia Mangiacavalli, Maria E Nizzoli, Elena Flospergher, Caterina Zerbi, Fabio Bergamini, Pietro Benvenuti, Marco Brociner, Gabriele Merati, Marco Paulli, Luca Arcaini
A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders. British journal of haematology 187 (4) (2019)

Marzia Varettoni.css-eqlu8i{font-size:small;padding-left:4px;} (M Varettoni)

Publication Activity (10 Years)

Top Topics

Top Venues

Marzia Varettoni (M Varettoni)